Enhancement of the antibody-dependent cellular cytotoxicity of human peripheral blood lymphocytes with interleukin-2 and interferon α (Q58620110)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

Enhancement of the antibody-dependent cellular cytotoxicity of human peripheral blood lymphocytes with interleukin-2 and interferon alpha (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

author name string

W M Vuist

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

M J Visseren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

M Otsen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

K Bos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

F A Vyth-Dreese

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

C J Melief

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

A Hekman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

12 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

163-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01741087

12 October 2019

exact match

0 references

cites work

Interferon Enhanced Human Natural Killer and Antibody-Dependent Cell-Mediated Cytotoxic Activity

1 reference

12 December 2020

Mechanism of human monocyte activation via the 40-kDa Fc receptor for IgG

1 reference

12 December 2020

Potentiation by interleukin 2 of Burkitt's lymphoma therapy with anti-pan B (anti-CD19) monoclonal antibodies in a mouse xenotransplantation model

1 reference

12 December 2020

Immunosuppressive effects of recombinant interferon-alpha during long-term treatment of cancer patients.

1 reference

12 December 2020

Biological response modifiers: the new immunotherapy.

1 reference

12 December 2020

Biological Activity of Recombinant Human Interleukin-2 Produced inEscherichia coli

1 reference

12 December 2020

Characterization of IL-2-induced murine cells which exhibit ADCC activity

1 reference

12 December 2020

Comparative studies of human FcRIII-positive and negative natural killer cells

1 reference

12 December 2020

Monoclonal antibodies to Fc receptors for IgG on human mononuclear phagocytes. Antibody characterization and induction of superoxide production in a monocyte cell line

1 reference

12 December 2020

Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-alpha and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody

1 reference

12 December 2020

Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes

1 reference

12 December 2020

Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma

1 reference

12 December 2020

Isolation of large numbers of highly purified lymphocytes and monocytes with a modified centrifugal elutriation technique.

1 reference

12 December 2020

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

1 reference

12 December 2020

Biochemical and functional characteristics of the human leukocyte membrane antigen family LFA-1, Mo-1 and p!50,95

1 reference

12 December 2020

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype

1 reference

12 December 2020

Treatment of a murine B cell lymphoma with monoclonal antibodies and IL 2.

1 reference

12 December 2020

The inhibitory effect of human interferon alpha on the generation of lymphokine-activated killer activity

1 reference

12 December 2020

QUANTITATIVE TITRATIONS OF MOUSE H-2 ANTIBODIES USING Cr51-LABELLED TARGET CELLS

1 reference

12 December 2020

Evidence that types I and II interferons have different receptors

1 reference

12 December 2020

Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity

1 reference

12 December 2020

Differential effects of recombinant interferons alpha, beta, and gamma on induction of human lymphokine (IL-2)-activated killer activity

1 reference

12 December 2020

Clinical immunotherapy studies in the Surgery Branch of the U.S. National Cancer Institute: brief review

1 reference

12 December 2020

Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes

1 reference

12 December 2020

Specific enhancement of the therapeutic effect of anti-idiotype antibodies on a murine B cell lymphoma by IL-2

1 reference

12 December 2020

Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors

1 reference

12 December 2020

On the mode of action of LFA-1.

1 reference

12 December 2020

Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activity of natural and activated killer cells and cloned CTL lines.

1 reference

12 December 2020

Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphoma

1 reference

12 December 2020

Interleukin-2: inception, impact, and implications

1 reference

12 December 2020

Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin

1 reference

12 December 2020

Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.

1 reference

12 December 2020

A monoclonal antibody (NKI-L16) directed against a unique epitope on the alpha-chain of human leukocyte function-associated antigen 1 induces homotypic cell-cell interactions

1 reference

12 December 2020

Mouse monoclonal antibodies against the idiotype of human B cell non-Hodgkin lymphomas: production, characterization and use to monitor the progress of disease

1 reference

12 December 2020

Both Fc receptors and lymphocyte-function-associated antigen 1 on human T gamma lymphocytes are required for antibody-dependent cellular cytotoxicity (killer cell activity)

1 reference

12 December 2020

Identification of a second class of IgG Fc receptors on human neutrophils. A 40 kilodalton molecule also found on eosinophils

1 reference

12 December 2020

Two distinct mechanisms of antitumor activity mediated by the combination of interleukin 2 and monoclonal antibodies

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01741087

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8439976%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference